Artificial Touch Enabled

A quadriplegic 28-year-old man senses touch via stimulation of electrodes implanted in his somatosensory cortex.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researcher Rob Gaunt prepares Nathan Copeland for sensory testing.UPMC/PITT HEALTH SCIENCESFollowing surgery to connect his brain to an array of electrodes, Nathan Copeland, who was paralyzed from the upper chest down in a car accident in 2004, experienced a natural touch sensation in response to stimulation of his sensory cortex, according to a study published today (October 13) in Science Translational Medicine.

“For most tasks that involve manipulation of objects, you’re really relying on the sense of touch to guide movement—you’re not using vision, necessarily,” study coauthor Jennifer Collinger of the University of Pittsburgh told Scientific American. “You don’t have any visual feedback on how hard you’re squeezing it, or what you need to do to maintain stable posture. All of that comes from the sense of touch.”

The researchers implanted a microelectrode array in Copeland’s somatosensory cortex, the brain region involved in touch perception. Once implanted, the researchers delivered mild electrical currents to the electrodes, which can be hooked up to a smart prosthetic arm. Initially, Copeland felt nothing, but after about a month, the microstimulation began to produce tactile sensations, which he described as “possibly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies